Safety Pharmacology assessment of drugs with biased 5-HT2B receptor agonism mediating cardiac valvulopathy

2013/12/19 by Icilio Cavero, Jean‐Michel Guillon, Jean-Michel Guillon · 2 citations
Medicine · Neuroscience · #Cardiac electrophysiology and arrhythmias #Neurotransmitter Receptor Influence on Behavior #Pharmacology and Obesity Treatment

paper · doi:10.1016/j.vascn.2013.12.004

openalex publication_date 2013/12/19 · crossref created 2013/12/19 · crossref issued 2014/03/01 · crossref published 2014/03/01 · crossref published-print 2014/03/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/20 · crossref indexed 2026/07/28 · openalex updated_date 2026/07/28

Citations

• Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine
• Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment

Cited by

• Updated European Consensus Statement on diagnosis and treatment of adult ADHD
• MDMA [wikipedia]